L. Chevret, Intoxications graves : prise en charge en réanimation pédiatrique. Arch Pédiatrie, pp.680-682, 2004.

A. Aouba, F. Péquinot, L. Camelin, F. Laurent, and E. Jougla, La mortalité par suicide en France en 2006, pp.1-8, 2009.

C. Chan-chee and D. Jezewski?serra, Hospitalisations pour tentatives de suicide entre 2004 et 2007 en France métropolitaine Analyse du PMSI-MCO [Internet] Available from: http://www.invs.sante.fr/Publications-et-outils/BEH-Bulletin- epidemiologique-hebdomadaire/Archives, pp.47-48, 2011.

K. Hawton, E. Townsend, J. Deeks, L. Appleby, D. Gunnell et al., Effects of legislation restricting pack sizes of paracetamol and salicylate on self poisoning in the United Kingdom: before and after study, BMJ, vol.322, issue.7296, p.1203, 2001.
DOI : 10.1136/bmj.322.7296.1203

B. Bannwarth and C. Richez, Controverse sur le dextropropoxyph??ne, Revue du Rhumatisme, vol.76, issue.7, pp.599-601, 2009.
DOI : 10.1016/j.rhum.2009.04.002

G. Osterloh, E. Friderichs, F. Felgenhauer, W. Günzler, Z. Henmi et al., General pharmacological studies on tramadol, a potent analgetic agent (author's transl)], Arzneimittelforschung, vol.28, issue.1a, pp.135-51, 1978.

O. Pricara, Available from: http://www.fda.gov/ohrms

D. Abadie, G. Durrieu, A. Roussin, J. Montastruc, and L. Réseau, Français des Centres Régionaux de Pharmacovigilance. Effets indésirables « graves » du tramadol : bilan 2010-2011 de pharmacovigilance en France. Thérapie, pp.77-84, 2013.

A. Boumendjel, S. Taïwe, G. , N. Bum, E. Chabrol et al., Occurrence of the Synthetic Analgesic Tramadol in an African Medicinal Plant, Angewandte Chemie International Edition, vol.66, issue.45, pp.11780-11784, 2013.
DOI : 10.1002/anie.201305697

URL : https://hal.archives-ouvertes.fr/inserm-00874145

M. Schmidt and . Sarcocephalus-latifolius, Available from: http://upload.wikimedia.org/wikipedia/commons/c/c2/Sarcocephalus_latifolius_MS _0970.jpg 12. Küçük A, Kad?o?lu Y. Determination of tramadol hydrochloride in ampoule dosage forms by using UV spectrophotometric and HPLC-DAD methods in methanol and water media. Il Farm, Feb, vol.60, issue.2, pp.163-172, 2005.

R. Raffa, E. Friderichs, W. Reimann, R. Shank, E. Codd et al., Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an " atypical " opioid analgesic, J Pharmacol Exp Ther, 1992.

L. Scott and C. Perry, Tramadol, Drugs, vol.9, issue.11, pp.139-76, 2000.
DOI : 10.2165/00003495-200060010-00008

A. Contramal and L. , Available from: http://agenceprd .ansm.sante.fr/php/ecodex/frames.php?specid=66406208&typedoc=R&ref=R0 231258, specid=65657321&typedoc=R&ref=R0 228726.htm 16. ANSM. RCP Monotramal [Internet]

C. Gillen, M. Haurand, D. Kobelt, and S. Wnendt, Affinity, potency and efficacy of tramadol and its metabolites at the cloned human mu-opioid receptor, Naunyn Schmiedebergs Arch Pharmacol. Jul, vol.18362, issue.2, pp.116-137, 2000.

Y. Ardakani, R. Mehvar, A. Foroumadi, and M. Rouini, Enantioselective determination of tramadol and its main phase I metabolites in human plasma by high-performance liquid chromatography, Journal of Chromatography B, vol.864, issue.1-2, pp.109-124, 2008.
DOI : 10.1016/j.jchromb.2008.01.038

B. Murthy and K. , Pharmacokinetics of tramadol in children after i.v. or caudal epidural administration, British Journal of Anaesthesia, vol.84, issue.3, pp.346-355, 2000.
DOI : 10.1093/oxfordjournals.bja.a013437

M. Frink, H. Hennies, W. Englberger, M. Haurand, and B. Wilffert, Influence of tramadol on neurotransmitter systems of the rat brain, Arzneimittelforschung, vol.46, issue.11, pp.1029-1065, 1996.

C. Lee, D. Mctavish, E. Sorkin, and . Tramadol, Tramadol, Drugs, vol.46, issue.2, pp.313-353, 1993.
DOI : 10.2165/00003495-199346020-00008

P. Oliva, C. Aurilio, F. Massimo, A. Grella, S. Maione et al., The antinociceptive effect of tramadol in the formalin test is mediated by the serotonergic component, European Journal of Pharmacology, vol.445, issue.3, pp.179-85, 2002.
DOI : 10.1016/S0014-2999(02)01647-3

P. Bloms-funke, E. Dremencov, T. Cremers, T. Tzschentke, . Hl et al., Tramadol increases extracellular levels of serotonin and noradrenaline as measured by in vivo microdialysis in the ventral hippocampus of freely-moving rats Nucleus raphe magnus inhibition of spinal cord dorsal horn neurons, Neurosci Lett. Brain Res, vol.490126, issue.33, pp.191-196, 1977.

P. Ginies, Atlas de la douleur imagée à la prescription commentée, 1999.

T. Bamigbade, C. Davidson, R. Langford, and J. Stamford, Actions of tramadol, its enantiomers and principal metabolite, O- desmethyltramadol, on serotonin (5-HT) efflux and uptake in the rat dorsal raphe nucleus, British Journal of Anaesthesia, vol.79, issue.3, 1997.
DOI : 10.1093/bja/79.3.352

V. Kayser, J. Besson, and G. Guilbaud, Evidence for a noradrenergic component in the antinociceptive effect of the analgesic agent tramadol in an animal model of clinical pain, the arthritic rat, European Journal of Pharmacology, vol.224, issue.1, pp.83-91, 1992.
DOI : 10.1016/0014-2999(92)94822-D

S. Andurkar, L. Gendler, and A. Gulati, Tramadol antinociception is potentiated by clonidine through ??-adrenergic and I?-imidazoline but not by endothelin ET(A) receptors in mice, Eur J Pharmacol, vol.683, pp.1-3109, 2012.

J. Vilardaga, V. Nikolaev, K. Lorenz, S. Ferrandon, Z. Zhuang et al., Conformational cross-talk between ??2A-adrenergic and ??-opioid receptors controls cell signaling, Nature Chemical Biology, vol.81, issue.2, pp.126-157, 2008.
DOI : 10.1038/sj.emboj.7600870

C. Jesse, E. Wilhelm, C. Bortolatto, and C. Nogueira, Evidence for the involvement of the noradrenergic system, dopaminergic and imidazoline receptors in the antidepressant-like effect of tramadol in mice, Pharmacology Biochemistry and Behavior, vol.95, issue.3, pp.344-50, 2010.
DOI : 10.1016/j.pbb.2010.02.011

M. Wasylewska, Effects of tramadol on ?2-adrenergic receptors in the rat brain, Brain Res, vol.1016, issue.2, pp.263-270, 2004.

B. Eassa and M. El-shazly, Safety and efficacy of tramadol hydrochloride on treatment of premature ejaculation, Asian Journal of Andrology, vol.15, issue.1, pp.138-180
DOI : 10.1038/aja.2012.96

Y. Al-haideri, Comparison of Local Anesthetic Efficacy of Tramadol Hydrochloride (With Adrenaline) Versus Plain Tramadol Hydrochloride in the Extraction of Upper Molar Teeth, Journal of Oral and Maxillofacial Surgery, vol.71, issue.12, pp.2035-2043, 2013.
DOI : 10.1016/j.joms.2013.08.009

M. Zarghami, B. Masoum, and M. Shiran, Tramadol versus Methadone for Treatment of Opiate Withdrawal: A Double-Blind, Randomized, Clinical Trial, Journal of Addictive Diseases, vol.283, issue.2, pp.112-119, 2012.
DOI : 10.1016/0014-2999(85)90539-4

S. Kampe, K. Wolter, M. Warm, O. Dagtekin, S. Shaheen et al., Clinical Equivalence of Controlled-Release Oxycodone 20 mg and Controlled-Release Tramadol 200 mg after Surgery for Breast Cancer, Pharmacology, vol.84, issue.5, pp.276-81, 2009.
DOI : 10.1159/000242998

F. Lin, W. Lin, C. Lai, C. Chen, C. Lin et al., Analgesic efficacy of tramadol/acetaminophen and propoxyphene/acetaminophen for relief of postoperative wound pain, Acta Anaesthesiologica Taiwanica, vol.50, issue.2, pp.49-53
DOI : 10.1016/j.aat.2012.05.009

M. Pandit, S. Godhi, and A. Lall, Preoperative Intravenous Tramadol Versus Diclofenac for Preventing Postoperative Pain After Third Molar Surgery: A Comparative Study, Journal of Maxillofacial and Oral Surgery, vol.31, issue.4, pp.306-315, 2011.
DOI : 10.1007/s12663-011-0250-9

. Once-daily, controlled-release tramadol and sustained-release diclofenac relieve chronic pain due to osteoarthritis: a randomized controlled trial, Pain Res Manag J Can Pain Soc J Société Can Pour Trait Douleur, vol.13, issue.2, pp.103-113, 2008.

R. Houmes, M. Voets, A. Verkaaik, W. Erdmann, and B. Lachmann, Efficacy and Safety of Tramadol Versus Morphine for Moderate and Severe Postoperative Pain With Special Regard to Respiratory Depression, Anesthesia & Analgesia, vol.74, issue.4, pp.510-514, 1992.
DOI : 10.1213/00000539-199204000-00007

G. Gritti, M. Verri, C. Launo, S. Palermo, G. Novelli et al., Multicenter trial comparing tramadol and morphine for pain after abdominal surgery, Drugs Exp Clin Res, vol.24, issue.1, pp.9-16, 1998.

U. Rüd, M. Fischer, R. Mewes, and D. Paravicini, Postoperative analgesia with tramadol. Continuous infusion versus repetitive bolus administration

H. Malonne, M. Coffiner, D. Fontaine, B. Sonet, A. Sereno et al., Long-term tolerability of tramadol LP, a new once-daily formulation, in patients with osteoarthritis or low back pain, Journal of Clinical Pharmacy and Therapeutics, vol.52, issue.3, pp.113-133, 2005.
DOI : 10.1016/S0885-3924(02)00642-5

A. Jonville-bera, M. A. Magba, D. Gedon, E. Autret-leca, and E. , Tramadolinduced hypoglycemia in a diabetic patient]. Thérapie, pp.499-500, 2010.

S. Taugourdeau, L. Chiche, F. Rouby, A. Default, M. Boyer et al., Severe hypoglycemia induced by tramadol: two new cases of an unlisted side effect]. Rev Médecine Interne Fondée Par Société Natl Francaise Médecine Interne, pp.703-708, 2011.

D. Sarret, L. Berre, J. Zemraoui, and N. , Tramadol-induced hyponatremia):1026; author reply 1027. 53 Tramadol-induced hyponatraemia following unicompartmental knee replacement surgery, Am J Kidney Dis Off J Natl Kidney Found Anaesthesia, vol.52, issue.5, 2005.

S. Ha, G. Se, D. V. Be, B. Dr, R. Mm et al., Prospective multicenter evaluation of tramadol exposure, J Toxicol Clin Toxicol, vol.35, issue.4, pp.361-365, 1996.

T. Saarikoski, T. Saari, T. Neuvonen, M. Neuvonen, P. Turpeinen et al., Futura- Sciences Available from: http://www.futura sciences.com/magazines/sante/infos/actu/d/medecine-tramadol-antidouleur-ligne- mire-afssaps-36269/ 56 Commission nationale des stupéfiants et des psychotropes -tramadol [Internet] Available from: http://ansm.sante.fr/var/ansm_site/storage/original/application Ticlopidine inhibits both O-demethylation and renal clearance of tramadol, increasing the exposure to it, but itraconazole has no marked effect on the ticlopidine-tramadol interaction, Eur J Clin Pharmacol, vol.69, issue.4, pp.867-75, 2013.

A. Elkalioubie, D. Allorge, L. Robriquet, J. Wiart, A. Garat et al., Near-fatal tramadol cardiotoxicity in a CYP2D6 ultrarapid metabolizer, European Journal of Clinical Pharmacology, vol.32, issue.8, pp.855-863, 2011.
DOI : 10.1007/s00228-011-1080-x

URL : https://hal.archives-ouvertes.fr/hal-00710456

H. Spiller, S. Gorman, D. Villalobos, B. Benson, D. Ruskosky et al., Prospective Multicenter Evaluation of Tramadol Exposure, Journal of Toxicology: Clinical Toxicology, vol.260, issue.4, pp.361-365, 1997.
DOI : 10.1016/S0196-0644(96)70116-6

K. Marquardt, J. Alsop, and T. Albertson, Tramadol Exposures Reported to Statewide Poison Control System, Annals of Pharmacotherapy, vol.36, issue.6, pp.1039-1083, 2005.
DOI : 10.1592/phco.20.19.1423.34854

J. Tobias, Seizure After Overdose of Tramadol, Southern Medical Journal, vol.90, issue.8, 1997.
DOI : 10.1097/00007611-199708000-00010

F. Musshoff and B. Madea, Fatality due to ingestion of tramadol alone, Forensic Science International, vol.116, issue.2-3, pp.197-206, 2001.
DOI : 10.1016/S0379-0738(00)00374-1

D. Uges, F. Clarot, J. Goullé, E. Vaz, and B. Proust, The International Association of Forensic Toxicologists therapeutic and toxic drug concentrations list [Internet] Available from: www.tiaft.org 64 Fatal overdoses of tramadol: is benzodiazepine a risk factor of lethality? Forensic Sci Int, pp.57-61, 2003.

T. Matthiesen, T. Wöhrmann, T. Coogan, and H. Uragg, The experimental toxicology of tramadol: an overview, Toxicology Letters, vol.95, issue.1, pp.63-71, 1998.
DOI : 10.1016/S0378-4274(98)00023-X

M. Loughrey, C. Loughrey, S. Johnston, O. Rourke, and D. , Fatal hepatic failure following accidental tramadol overdose, Forensic Science International, vol.134, issue.2-3, pp.2-3232, 2003.
DOI : 10.1016/S0379-0738(03)00132-4

D. Decker, K. Cordonnier, J. Jacobs, W. Coucke, V. Schepens et al., Fatal intoxication due to tramadol alone, Forensic Science International, vol.175, issue.1, pp.79-82, 2008.
DOI : 10.1016/j.forsciint.2007.07.010

C. Hignite and D. Azarnoff, Drugs and drug metabolites as environmental contaminants: Chlorophenoxyisobutyrate and salicylic acid in sewage water effluent, Life Sciences, vol.20, issue.2, pp.337-378, 1977.
DOI : 10.1016/0024-3205(77)90329-0

M. Bergheim, R. Gieré, and K. Kümmerer, Biodegradability and ecotoxicitiy of tramadol, ranitidine, and their photoderivatives in the aquatic environment, Environmental Science and Pollution Research, vol.13, issue.1
DOI : 10.1007/s11356-011-0536-y

E. Boyer, Management of Opioid Analgesic Overdose, New England Journal of Medicine, vol.367, issue.2, p.2012
DOI : 10.1056/NEJMra1202561

K. Moore, S. Cina, R. Jones, D. Selby, B. Levine et al., Tissue Distribution of Tramadol and Metabolites in an Overdose Fatality, The American Journal of Forensic Medicine and Pathology, vol.20, issue.1, pp.98-100, 1999.
DOI : 10.1097/00000433-199903000-00023

D. Backer, B. Renardy, F. Denooz, R. Charlier, and C. , Quantification in Postmortem Blood and Identification in Urine of Tramadol and Its Two Main Metabolites in Two Cases of Lethal Tramadol Intoxication, Journal of Analytical Toxicology, vol.34, issue.9, pp.599-604, 2010.
DOI : 10.1093/jat/34.9.599

S. Kimura, M. Umeno, R. Skoda, U. Meyer, and F. Gonzalez, The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene, Am J Hum Genet, vol.45, issue.6, pp.889-904, 1989.

L. Bertilsson, M. Dahl, P. Dalén, and A. Shurbaji, Molecular genetics of CYP2D6: Clinical relevance with focus on psychotropic drugs, British Journal of Clinical Pharmacology, vol.10, issue.2, pp.111-133, 2002.
DOI : 10.1046/j.0306-5251.2001.01548.x

R. Landau, Pharmacogenomic considerations in opioid analgesia, Pharmacogenomics and Personalized Medicine
DOI : 10.2147/PGPM.S23422

P. Daly, A. Brockmöller, J. Broly, F. Eichelbaum, M. Evans et al., 2012 Aug;73. 76 Nomenclature for human CYP2D6 alleles, Pharmacogenetics, 1996.

A. Levo, A. Koski, I. Ojanperä, E. Vuori, and A. Sajantila, Post-mortem SNP analysis of CYP2D6 gene reveals correlation between genotype and opioid drug (tramadol) metabolite ratios in blood, Forensic Science International, vol.135, issue.1, pp.9-15, 2003.
DOI : 10.1016/S0379-0738(03)00159-2

C. Randall and J. Crane, Tramadol deaths in Northern Ireland: A review of cases from 1996 to 2012, Journal of Forensic and Legal Medicine, vol.23, pp.32-38
DOI : 10.1016/j.jflm.2014.01.006

H. P. Rang, M. M. Dale, J. M. Ritter, and P. K. Moore, Other peripheral mediators: 5-hydroxytryptamine and purines, Pharmacology, 2003.
DOI : 10.1016/B978-0-443-06911-6.50017-7

D. Hoyer, J. Hannon, and G. Martin, Molecular, pharmacological and functional diversity of 5-HT receptors, Pharmacology Biochemistry and Behavior, vol.71, issue.4, pp.533-54, 2002.
DOI : 10.1016/S0091-3057(01)00746-8

K. Nisijima, T. Yoshino, K. Yui, and S. Katoh, Potent serotonin (5-HT)2A receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome, Brain Research, vol.890, issue.1, pp.23-31, 2001.
DOI : 10.1016/S0006-8993(00)03020-1

P. Gillman, A Review of Serotonin Toxicity Data: Implications for the Mechanisms of Antidepressant Drug Action, Biological Psychiatry, vol.59, issue.11, pp.1046-51, 2006.
DOI : 10.1016/j.biopsych.2005.11.016

E. Dunkley, G. Isbister, D. Sibbritt, A. Dawson, and I. Whyte, The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity, QJM, vol.96, issue.9, pp.635-677, 2003.
DOI : 10.1093/qjmed/hcg109

H. Sternbach, The serotonin syndrome, Am J Psychiatry, 1991.

R. Bédry and E. Sudre, Le syndrome sérotoninergique. Prat En Anesth Réanimation, pp.278-82, 2009.

E. Boyer and M. Shannon, The Serotonin Syndrome, New England Journal of Medicine, vol.352, issue.11, pp.1112-1132, 2005.
DOI : 10.1056/NEJMra041867

R. Boostani, S. Derakhshan, K. Soltaninejad, K. Heydari, G. Sasanian et al., Tramadol induced seizure: A 3-year study Tramadol intoxication: a review of 114 cases, Casp J Intern Med. Hum Exp Toxicol, vol.327, issue.33, pp.201-206, 2008.

H. Hassanian-moghaddam, H. Farajidana, S. Sarjami, H. Owliaey, and . Tramadolinduced-apnea, Tramadol-induced apnea, The American Journal of Emergency Medicine, vol.31, issue.1, pp.26-31
DOI : 10.1016/j.ajem.2012.05.013

V. Jovanovi?-?upi?, ?. Martinovi?, and N. Ne?i?, Seizures associated with intoxication and abuse of tramadol [Internet] Available from, 2008.

H. Talaie, R. Panahandeh, M. Fayaznouri, Z. Asadi, and M. Abdollahi, Dose-independent occurrence of seizure with tramadol, Journal of Medical Toxicology, vol.27, issue.1, pp.63-70, 2009.
DOI : 10.1007/BF03161089

A. Rehni, I. Singh, and M. Kumar, Tramadol-Induced Seizurogenic Effect: A Possible Role of Opioid-Dependent ??-Aminobutyric Acid Inhibitory Pathway, Basic & Clinical Pharmacology & Toxicology, vol.105, issue.3, pp.262-268, 2008.
DOI : 10.1111/j.1742-7843.2008.00276.x

H. Potschka, E. Friderichs, and W. Löscher, Anticonvulsant and proconvulsant effects of tramadol, its enantiomers and its M1 metabolite in the rat kindling model of epilepsy, British Journal of Pharmacology, vol.18, issue.Suppl., pp.203-215, 2000.
DOI : 10.1038/sj.bjp.0703562

A. Rehni, T. Singh, N. Singh, and S. Arora, Tramadol-induced seizurogenic effect: a possible role of opioid-dependent histamine (H1) receptor activation-linked mechanism, Naunyn-Schmiedeberg's Archives of Pharmacology, vol.36, issue.3, pp.11-20, 2010.
DOI : 10.1007/s00210-009-0476-y

F. Baud, ??tude du m??canisme des overdoses aux opio??des??: apport de l???exp??rimental ?? la clinique, Annales Pharmaceutiques Fran??aises, vol.67, issue.5, pp.353-362, 2009.
DOI : 10.1016/j.pharma.2009.06.005

B. Mégarbane, Opioïdes : toxicité et implications cliniques Available from: http://www.chu-rouen.fr/page/doc/DOC_202741 99. Zacny JP. Profiling the subjective, psychomotor, and physiological effects of tramadol in recreational drug users. Drug Alcohol Depend, pp.273-281, 2005.

M. Emamhadi, H. Sanaei-zadeh, M. Nikniya, N. Zamani, and R. Dart, Electrocardiographic manifestations of tramadol toxicity with special reference to their ability for prediction of seizures, The American Journal of Emergency Medicine, vol.30, issue.8, pp.1481-1486, 2012.
DOI : 10.1016/j.ajem.2011.12.009

J. Cole, S. Sattiraju, E. Bilden, R. Asinger, and S. Bertog, Isolated Tramadol Overdose Associated with Brugada ECG Pattern, Pacing and Clinical Electrophysiology, vol.27, issue.8, pp.219-221, 2012.
DOI : 10.1111/j.1540-8159.2010.02924.x

G. Haeseler, N. Foadi, J. Ahrens, R. Dengler, H. Hecker et al., Tramadol, fentanyl and sufentanil but not morphine block voltage-operated sodium channels, Pain, vol.126, pp.1-3234, 2006.

P. Kolecki and S. Curry, POISONING BY SODIUM CHANNEL BLOCKING AGENTS, Critical Care Clinics, vol.13, issue.4, pp.829-877, 1997.
DOI : 10.1016/S0749-0704(05)70371-7

R. Wagner, P. Piler, H. Bedanova, P. Adamek, L. Grodecka et al., Myocardial injury is decreased by late remote ischaemic preconditioning and aggravated by tramadol in patients undergoing cardiac surgery: a randomised controlled trial, Interactive CardioVascular and Thoracic Surgery, vol.11, issue.6, pp.758-62, 2010.
DOI : 10.1510/icvts.2010.243600

R. Schlienger, L. Fischer, H. Jick, and C. Meier, Current Use of Selective Serotonin Reuptake Inhibitors and Risk of Acute Myocardial Infarction, Drug Safety, vol.57, issue.2, pp.1157-65, 2004.
DOI : 10.2165/00002018-200427140-00006

G. Mannocchi, F. Napoleoni, S. Napoletano, F. Pantano, M. Santoni et al., Fatal self administration of tramadol and propofol: A case report, Journal of Forensic and Legal Medicine, vol.20, issue.6, pp.715-724, 2013.
DOI : 10.1016/j.jflm.2013.04.003

C. Daubin, C. Quentin, J. Goullé, D. Guillotin, P. Lehoux et al., Refractory shock and asystole related to tramadol overdose, Clinical Toxicology, vol.34, issue.8, 2007.
DOI : 10.1016/j.ejphar.2005.11.028

P. Högger, Adverse effects of opioid analgesic treatment are correlated with a significant elevation in plasma epinephrine in healthy humans, Eur J Clin Pharmacol, vol.56, pp.6-7463, 2000.

E. Garciaquetglas, J. Azanza, B. Sadaba, M. Munoz, I. Gil et al., Pharmacokinetics of tramadol enantiomers and their respective phase I metabolites in relation to CYP2D6 phenotype, Pharmacological Research, vol.55, issue.2, 2007.
DOI : 10.1016/j.phrs.2006.11.003

L. Mildh, K. Leino, and O. Kirvelä, Effects of tramadol and meperidine on respiration, plasma catecholamine concentrations, and hemodynamics, Journal of Clinical Anesthesia, vol.11, issue.4, pp.310-316, 1999.
DOI : 10.1016/S0952-8180(99)00047-1

J. Raimundo, L. Pontes, F. Antunes, R. Sudo, M. Trachez et al., COMPARATIVE EFFECTS OF TRAMADOL ON VASCULAR REACTIVITY IN NORMOTENSIVE AND SPONTANEOUSLY HYPERTENSIVE RATS, Clinical and Experimental Pharmacology and Physiology, vol.10, issue.Suppl. 1, 2008.
DOI : 10.1111/j.1440-1681.2008.04979.x

B. Müller and K. Wilsmann, Cardiac and hemodynamic effects of the centrally acting analgesics tramadol and pentazocine in anaesthetized rabbits and isolated guinea-pig atria and papillary muscles, Arzneimittelforschung, vol.34, issue.4, pp.430-433, 1984.

P. Lancellotti and M. Moonen, La sidération myocardique vue par le réanimateur. Réanimation, pp.191-197, 2009.

A. Prasad, A. Lerman, and C. Rihal, Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): A mimic of acute myocardial infarction, American Heart Journal, vol.155, issue.3, pp.408-425, 2008.
DOI : 10.1016/j.ahj.2007.11.008

P. Garrett, Tramadol overdose and serotonin syndrome manifesting as acute right heart dysfunction. Anaesth Intensive Care, pp.575-582, 2004.

S. Wang, C. Li, and Y. Song, Multiply organ dysfunction syndrome due to tramadol intoxication alone, The American Journal of Emergency Medicine, vol.27, issue.7, pp.903-908, 2009.
DOI : 10.1016/j.ajem.2008.11.013

N. Mugunthan and P. Davoren, Danger of Hypoglycemia Due to Acute Tramadol Poisoning, Endocrine Practice, vol.18, issue.6, pp.151-152, 2012.
DOI : 10.4158/EP12070.CR

R. Raffa, C. Wu, D. Stone, M. Borenstein, E. Codd et al., Determination of the adsorption of tramadol hydrochloride by activated charcoal in vitro and in vivo, Journal of Pharmacological and Toxicological Methods, vol.43, issue.3, pp.205-215, 2000.
DOI : 10.1016/S1056-8719(00)00091-5

H. Khosrojerdi, R. Afshari, and O. Mehrpour, Should activated charcoal be given after tramadol overdose?, DARU Journal of Pharmaceutical Sciences, vol.21, issue.1, p.46, 2013.
DOI : 10.3109/15563651003709427

P. Chyka, D. Seger, E. Krenzelok, and J. Vale, American Academy of Clinical Toxicology, European Association of Poisons Centres and Clinical Toxicologists. Position paper: single-dose activated charcoal, Clin Toxicol Phila Pa, vol.43, issue.2, pp.61-87, 2005.

B. Mégarbane, L. Donetti, T. Blanc, G. Chéron, and F. Jacobs, Intoxications graves par??m??dicaments et??substances illicites en??r??animation, R??animation, vol.15, issue.5, 2006.
DOI : 10.1016/j.reaurg.2006.07.006

. Poisindex, Micromedex® Healthcare series [Internet] Available from: http://www.micromedexsolutions.com

C. Daubin, P. Lehoux, C. Ivascau, M. Tasle, M. Bousta et al., Extracorporeal life support in severe drug intoxication: a retrospective cohort study of seventeen cases, Critical Care, vol.13, issue.4, p.138, 2009.
DOI : 10.1186/cc8017

R. Masson, V. Colas, J. Parienti, P. Lehoux, M. Massetti et al., A comparison of survival with and without extracorporeal life support treatment for severe poisoning due to drug intoxication, Resuscitation, vol.83, issue.11, pp.1413-1420, 2012.
DOI : 10.1016/j.resuscitation.2012.03.028

P. Perry and C. Wilborn, Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management, Ann Clin Psychiatry Off J Am Acad Clin Psychiatr. 2012, vol.24, issue.2, pp.155-62

M. Vahabzadeh, M. Moshiri, A. Mohammadpour, and H. Hosseinzadeh, Promising Effects of Intravenous Lipid Emulsion as an Antidote in Acute Tramadol Poisoning, Regional Anesthesia and Pain Medicine, vol.38, issue.5, pp.425-455, 2013.
DOI : 10.1097/AAP.0b013e31829f644b

M. Bartos and K. Knudsen, Use of intravenous lipid emulsion in the resuscitation of a patient with cardiovascular collapse after a severe overdose of quetiapine, Clinical Toxicology, vol.63, issue.6, pp.501-505
DOI : 10.3109/15563650903544124

P. Nisse, Le screening toxicologique aux urgences, Congrès Urgences, pp.133-178, 2010.

A. Curticapean, D. Muntean, M. Curticapean, M. Dogaru, and C. Vari, Optimized HPLC method for tramadol and O-desmethyl tramadol determination in human plasma, Journal of Biochemical and Biophysical Methods, vol.70, issue.6, pp.1304-1316, 2008.
DOI : 10.1016/j.jprot.2008.01.012

M. Bartoli, C. Berny, B. Capolaghi, V. Danel, A. Delahaye et al., Recommandations pour la prescription, la réalisation et l'interprétation des examens de biologie médicale dans le cadre des intoxications graves. Immuno- Anal Biol Spéc, pp.251-73, 2013.

S. Bismuth, E. Leng, S. Oustric, J. Montastruc, and M. Lapeyre-mestre, Which analgesic after dextropropoxyphene withdrawal? A survey in a sample of general practitioners in southwest of France]. Thérapie, Feb, vol.66, issue.1, pp.25-33, 2011.

P. Saviuc, Exposition aux antalgiques de palier 2 : mise à jour du recueil de cas à partir des centres antipoison et de toxicovigilance

H. Persson, G. Sjöberg, J. Haines, and J. Pronczuk-de-garbino, Poisoning Severity Score. Grading of Acute Poisoning, Journal of Toxicology: Clinical Toxicology, vol.106, issue.3, pp.205-218, 1998.
DOI : 10.1136/bmj.2.6028.153

C. Cabot, P. Saviuc, and A. Villa, Définition des critères de gravité d'une intoxication médicamenteuse

P. Saviuc, Expositions par les antalgiques de palier 2 dextropropoxyphène, tramadol et codéine dans les centres antipoison français, 2000.

A. El-hussuna, R. Arnesen, and J. Rosenberg, Tramadol poisoning with hyperamylasemia, Case Reports, vol.2010, issue.aug06 1, 2010.
DOI : 10.1136/bcr.03.2010.2821

A. Dziewierz, K. Ciszowski, T. Gawlikowski, T. Rakowski, P. Kleczy?ski et al., Primary Angioplasty in Patient with St-Segment Elevation Myocardial Infarction in the Setting of Intentional Carbon Monoxide Poisoning, The Journal of Emergency Medicine, vol.45, issue.6, pp.831-835, 2013.
DOI : 10.1016/j.jemermed.2013.05.061

G. Lippi, G. Rastelli, T. Meschi, L. Borghi, and G. Cervellin, Pathophysiology, clinics, diagnosis and treatment of heart involvement in carbon monoxide poisoning, Clinical Biochemistry, vol.45, issue.16-17, pp.16-171278, 2012.
DOI : 10.1016/j.clinbiochem.2012.06.004

P. Saviuc and R. Garnier, A-t-on raison de retirer du marché les spécialités à base de dextropropoxyphène ? Réanimation, pp.466-70, 2010.